Page 30 - Exact Sciences News Today

Sanford C. Bernstein assumed coverage on shares of Exact Sciences (NASDAQ:EXAS – Free Report) in a research report released on Thursday, MarketBeat reports. The firm issued an outperform rating and a $83.00 price target on the medical research company’s stock. A number of other brokerages also recently issued reports on EXAS. Piper Sandler lifted their […]

The UW-Madison visit is expected to be rescheduled, as Harris is looking forward to coming to Madison in the future, a White House official said.

These two cutting-edge healthcare companies could be significantly undervalued right now.

These two cutting-edge healthcare companies could be significantly undervalued right now.

The UW-Madison visit is expected to be rescheduled, as Harris is looking forward to coming to Madison in the future, a White House official said.

The UW-Madison visit is expected to be rescheduled, as Harris is looking forward to coming to Madison in the future, a White House official said.

The 2024 Cologuard Classic will be played at La Paloma Country Club for the first time. Despite the venue change, the tournaments mission remains the same.

Today's Research Daily features new research reports on 12 major stocks, including Adobe Inc. (ADBE), S&P Global Inc. (SPGI) and Arista Networks, Inc. (ANET).

The ARK Invest founder discusses the promise of AI, thematic investing, and why she doesn’t regret sitting out Nvidia’s latest moon rally.

Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year target […]